Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.71B |
| 2 |
TSMC
TSM
|
+$1.27B |
| 3 |
Eaton
ETN
|
+$1.13B |
| 4 |
XYZ
Block Inc
XYZ
|
+$1.03B |
| 5 |
Analog Devices
ADI
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.01B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.61B |
| 3 |
Apple
AAPL
|
+$1.43B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.43B |
| 5 |
UnitedHealth
UNH
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.77% |
| 2 | Healthcare | 14.55% |
| 3 | Financials | 10.98% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Wave Life Sciences
WVE
$1.1B
| $4.48M | ﹤0.01% |
1,035,536
-725,900
| -41% | -$3.33M |
|
2002
Sigma Lithium
SGML
$1.33B
| $4.48M | ﹤0.01% |
+119,055
| New | +$3.81M |
|
2003
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$323M
| $4.47M | ﹤0.01% |
178,435
-25,000
| -12% | -$614K |
|
|
RGF
2004
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $4.43M | ﹤0.01% |
87,382
| – | – |
|
2005
QuidelOrtho
QDEL
$964M
| $4.42M | ﹤0.01% |
49,657
+15,705
| +46% | +$1.37M |
|
2006
Bloomin' Brands
BLMN
$953M
| $4.41M | ﹤0.01% |
172,102
-44,842
| -21% | -$1.11M |
|
|
AVDX
2007
DELISTED
AvidXchange
AVDX
| $4.41M | ﹤0.01% |
565,520
+464,584
| +460% | +$4.47M |
|
2008
First Commonwealth Financial
FCF
$2.19B
| $4.36M | ﹤0.01% |
351,012
+276,057
| +368% | +$3.98M |
|
2009
iShares MSCI ACWI ETF
ACWI
$33.3B
| $4.34M | ﹤0.01% |
47,595
+1,328
| +3% | +$118K |
|
2010
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.78B
| $4.33M | ﹤0.01% |
171,497
+5,758
| +3% | +$143K |
|
2011
Myers Industries
MYE
$1.22B
| $4.33M | ﹤0.01% |
202,052
+6,724
| +3% | +$153K |
|
2012
Oak Valley Bancorp
OVLY
$281M
| $4.3M | ﹤0.01% |
181,921
+4,000
| +2% | +$101K |
|
|
AMNB
2013
DELISTED
American National Bankshares Inc
AMNB
| $4.23M | ﹤0.01% |
133,335
-1,303
| -1% | -$44.1K |
|
2014
Navient
NAVI
$810M
| $4.17M | ﹤0.01% |
261,087
-2,560,330
| -91% | -$44.7M |
|
2015
Lincoln National
LNC
$8.6B
| $4.14M | ﹤0.01% |
184,192
-232,590
| -56% | -$6.92M |
|
2016
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $4.11M | ﹤0.01% |
40,664
+4,651
| +13% | +$468K |
|
2017
American States Water
AWR
$3.47B
| $4.1M | ﹤0.01% |
46,148
-8,038
| -15% | -$734K |
|
|
CYT
2018
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $4.1M | ﹤0.01% |
2,252,331
-656,045
| -23% | -$1.07M |
|
2019
Frontier Group Holdings
ULCC
$1.59B
| $4.09M | ﹤0.01% |
415,825
+8,821
| +2% | +$98.5K |
|
2020
Atlantic Union Bankshares
AUB
$6.03B
| $4.07M | ﹤0.01% |
116,112
+42,233
| +57% | +$1.56M |
|
2021
Beyond Meat
BYND
$215M
| $4.07M | ﹤0.01% |
250,679
+247,936
| +9,039% | +$4.08M |
|
2022
Vanguard Total International Stock ETF
VXUS
$162B
| $4.06M | ﹤0.01% |
73,609
+17,748
| +32% | +$970K |
|
|
INZY
2023
DELISTED
Inozyme Pharma
INZY
| $4.03M | ﹤0.01% |
+702,996
| New | +$1.86M |
|
2024
Nurix Therapeutics
NRIX
$2.72B
| $4M | ﹤0.01% |
450,244
-553,399
| -55% | -$5.77M |
|
2025
Rocket Pharmaceuticals
RCKT
$376M
| $4M | ﹤0.01% |
233,231
-25,929
| -10% | -$508K |
|
Similar funds
Fidelity Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Fidelity Investments held 5,689 positions worth $1.09T, up 8.6% from $1.01T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Fidelity Investments's Q1 2023 filing shows 342 new, 2,555 increased, 1,824 reduced and 420 closed positions. Its largest new stake was GE HealthCare: 13,666,317 shares worth $1.12B. The largest sale was Amazon, an estimated $2.01B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2023 buy was GE HealthCare: 13,666,317 shares worth $1.12B.
- Fidelity Investments added most to iShares 7-10 Year Treasury Bond ETF in Q1 2023, an estimated $2.71B increase.
- Fidelity Investments's biggest Q1 2023 reduction was Amazon, cutting an estimated $2.01B.
- Fidelity Investments fully exited Signature Bank in Q1 2023, selling an estimated $297M.
- Fidelity Investments's ten largest holdings make up 26% of its $1.09T portfolio in Q1 2023.
- Fidelity Investments opened 342 new positions and closed 420 in Q1 2023.
- Fidelity Investments's portfolio value rose 8.6% quarter-over-quarter to $1.09T.
Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.